Ricevi le ultime notizie sulle azioni Absci con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di ABSI

Ultime notizie per

ABSCI CORP

Absci

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

News

ABSI

ACCD

ARKG

ARKK

ARKQ

ARKX

ESLT

ILMN

NTLA

OKLO

PATH

Scopri come queste strategie potrebbero influenzare il mercato e cosa riserva il futuro per questi investimenti.

Ecco in quali società sta investendo Cathie Wood tramite Ark

Absci Corp

Health Care

Press Releases

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Earnings

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Absci to Participate in Upcoming Investor Conferences

Management

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

iRhythm Technologies Announces Board Member Retirements and New Director Appointments

IPOs

Absci Announces Proposed Public Offering of Common Stock

Absci Announces Pricing of Public Offering of Common Stock

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

ATEC

IRTC

Abeona Therapeutics

Astria Therapeutics

Aura Biosciences

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Compass Therapeutics, Inc. - Common Stock

Compass Therapeutics

Emergent BioSolutions

Erasca

Gossamer Bio

I-MAB

ITeos Therapeutics

Kamada

Larimar Therapeutics, Inc. - Common Stock

Larimar Therapeutics

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

Nanobiotix

Prothena Corporation plc - Ordinary Shares

Prothena Corp

PureTech Health plc - American Depositary Shares

PureTech Health

Replimune Group

Regenxbio

Solid Biosciences

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals

Verastem

XOMA Royalty

Y-mAbs Therapeutics

Needham

Morgan Stanley

Keybanc

Guggenheim

HC Wainwright & Co.

Comments

Absci Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO